UNC alum, pharmaceutical exec Fred Eshelman makes another investment: experimental cancer treatment

Posted Apr 28, 2015
Fred Eshelman made another move by joining a group that invested $28 million in Innocrin Pharmaceuticals, a company developing treatments for breast and prostate cancers. Eshelman, who recently founded Eshelman Ventures, also joined Innocrin's board. (Triangle Business Journal)

Related: Campus Connections

New Zaxbys location to open on Franklin Street
Zaxbys is set to open a new location on 127 East Franklin Street between Blue Horn Lounge and Cold Stone Creamery. The Town is doing...
Thu Jan 23, 2025

January 15, 1975: UNC Opened Its Doors, With Little Fanfare
On a cold and muddy winter morning 230 years ago, UNC officially opened its doors, though it didn’t have many doors to open. On Jan...
Tue Jan 21, 2025

Hundreds of UNC Alumni Affected by California Wildfires
The homes of nearly 400 UNC alumni were in the path or in evacuation zones of fast-moving destructive fires that began Jan. 7 in the...
Mon Jan 20, 2025

'This was a life': UNC community gathers for memorial to honor James Cates
James Cates Jr., a Black Chapel Hill resident, was murdered by members of a white supremacist motorcycle gang outside of the Carolina Union on Nov...
Sun Jan 19, 2025